ArticleJournal of applied clinical medical physics2026
Clinical in-vivo dosimetry for total skin electron therapy using gafchromic™ EBT4 film.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTotal skin electron therapy (TSET) is a standard treatment for cutaneous T-cell lymphoma. Due to the complex patient positioning and irregular body contours, robust in-vivo dosimetry (IVD) is essential to verify dose uniformity. While thermoluminescent dosimeters (TLDs) are traditional standard, their utility is hindered by labor-intensive, manual processing. PURPOSES: This study evaluates the clinical implementation of a Gafchromic™ EBT4 film-based IVD system integrated with a bespoke, open-source analysis platform for automated batch-processing. To address the inherent orientation dependence and loss of film orientation frequently encountered when preparing small-format IVD films with a manual paper cutter, we developed an orthogonal dual-scan protocol. By averaging pixel values from two perpendicular scans for both calibration and clinical measurement, this protocol effectively mitigates orientation-dependent uncertainties and ensures dosimetric robustness.
methodsThe film-based IVD system was clinically assessed in five TSET treatments and compared to six treatments utilizing TLD-based IVD. Dosimetric accuracy was evaluated by comparing normalized fractional doses to the prescription. Statistical analysis was performed using the Mann-Whitney U test with the Benjamini-Hochberg procedure to control the false discovery rate across 20 anatomical sites. Workflow efficiency was quantified by the total time required for data readout and analysis per patient.
resultsThe EBT4 film-based IVD demonstrated dosimetric accuracy comparable to the TLDs, with mean fractional doses of 102.7% ± 9.6% and 100.4% ± 9.7%, respectively (p = 0.25). Clinical implementation of the film-based approach significantly enhanced efficiency, reducing the total processing time from approximately 50 min to 15 min per treatment.
conclusionsThe proposed EBT4 film-based IVD system, supported by open-source software and an orthogonal dual-scan protocol, offers a robust, cost-effective, and time-efficient alternative to traditional TLDs. This approach streamlines the clinical workflow without compromising dosimetric accuracy, making it a viable solution for TSET and broader radiotherapy IVD applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.